11th Nov 2008 17:00
Sinclair Pharma plc 2008 Annual Report and Accounts
11 November 2008, Godalming, UK: Sinclair Pharma plc ("Sinclair": SPH:L) (the "Company"), the international specialty pharma company, today announces that in accordance with listing rule 9.6.1, the annual report and accounts of the Company, a circular containing a summary of the proposed changes to the Company's articles of association and a notice concerning the Annual General Meeting of the Company together with the form of proxy for use at the Annual General Meeting, have been submitted to the UK Listing Authority and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility located at:
Financial Services Authority25 The North ColonnadeCanary WharfLondon E14 5HSTel: 020 7066 1000
Copies of the above documents are available from the registered office of Sinclair Pharma plc at Godalming Business Centre, Woolsack Way, Godalming, Surrey, GU7 1XW. The annual report and accounts of the Company and the circular containing the notice of Annual General Meeting and a copy of the draft articles of association are available on the Company's website at:
www.sinclairpharmair.com/investor_relations/annual_reports/
Enquiries
Capital MS&L
Mary Clark, Anna Mitchell Tel +44 (0)20 7307 5340
Notes to Editors:
About Sinclair Pharma Plc www.sinclairpharma.com
Sinclair Pharma plc is an international specialty pharmaceutical company. It has a growing sales and marketing operation that is already present in France, Italy, UK, Spain and Portugal, and a complementary marketing partner network that spans more than 80 countries.
Sinclair has proven expertise in acquiring or developing commercially attractive and undervalued products, registering these products and bringing them to market within a short timeframe. The company focuses on niche therapeutic areas and its current portfolio includes products for a wide range of dermatological conditions and oral health.
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward-looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward-looking statements due to a variety of factors.
vendorRelated Shares:
Sinclair Pharma